WallStreetZenWallStreetZen

NASDAQ: AVDL
Avadel Pharmaceuticals PLC Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Avadel Pharmaceuticals earnings were -$2.9M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest AVDL earnings report on Jun 30, 2025 announced Q2 2025 earnings of $9.7M, down 296.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVDL reported annual earnings of -$48.8M, with -69.5% growth.

AVDL earnings history

Current Revenue
$221.1M
Current Earnings
-$2.9M
Current Profit Margin
-1.3%

AVDL Return on Equity

Current Company
-3.7%
Current Industry
18.1%
Current Market
27%
AVDL's Return on Equity (-3.7%)... subscribe to Premium to read more.
High Return on Equity Performance

AVDL undefined

Current Company
-1.7%
Current Industry
7.1%
AVDL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AVDL announces earnings.

AVDL undefined

Current Company
3.28%
Current Industry
13.9%
AVDL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AVDL vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AVDL$7.86M-$2.92MN/A-$0.03
EVON/A-$180.85MN/A-$0.51
DVAX-$40.59M-$60.07MN/A-$0.49
AMPH$265.38M$141.63M+21.34%$2.92
PAHC$123.68M$31.79M-2.36%$0.79
View Top Pharmaceutical Stocks

Avadel Pharmaceuticals Earnings Reports & History FAQ

What were Avadel Pharmaceuticals's earnings last quarter?

On AVDL's earnings call on Invalid Date, Avadel Pharmaceuticals (NASDAQ: AVDL) reported Q2 2025 earnings per share (EPS) of $0.10, up 171.43% year over year. Total AVDL earnings for the quarter were $9.67 million. In the same quarter last year, Avadel Pharmaceuticals's earnings per share (EPS) was -$0.14.

If you're new to stock investing, here's how to buy Avadel Pharmaceuticals stock.

Is Avadel Pharmaceuticals profitable or losing money?

As of the last Avadel Pharmaceuticals earnings report, Avadel Pharmaceuticals is currently losing money. Avadel Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$2.92 million, a 97.25% decrease year over year.

What was AVDL's earnings growth in the past year?

As of Avadel Pharmaceuticals's earnings date in Invalid Date, Avadel Pharmaceuticals's earnings has grown year over year. AVDL earnings in the past year totalled -$2.92 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.